Latest Manufacturing News

Li-S Energy has secured a strategic defence collaboration, advanced its Pegasus I drone testing, and commissioned Australia's first lithium metal foil production line, all while maintaining a solid cash position.

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

Matrix Composites & Engineering has landed a significant A$35 million subsea buoyancy contract with a major international energy services firm, underpinning its growth trajectory into FY2026.

International Graphite Limited is advancing its strategy to become a global mine-to-market industrial graphite company, with a new joint venture in Germany and expansion of its Western Australian operations targeting production by 2027.

Kingsland Minerals has initiated a scoping study for graphite concentrate production at its Leliyn Graphite Project, supported by an updated Indicated Mineral Resource estimate. The study aims to assess the economic viability of a processing facility near Pine Creek, NT.

Epsilon Healthcare has emerged from voluntary administration with a stronger balance sheet, securing refinancing and preparing to launch its new pharmacy platform. Operational stability and strategic initiatives signal a turning point for the healthcare group.

Saferoads Holdings reports a $192k operating cash use impacted by strategic prepayments, completes its Road Safety Rentals asset sale, and maintains strong cash reserves after paying a substantial dividend.

Stealth Group Holdings reports a robust $6 million in pre-sales for iPhone 17 accessories, marking a 50% increase from last year and signaling strong momentum ahead of the global launch.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.

Clarity Pharmaceuticals has completed a $203 million institutional placement at a premium, bolstering its cash reserves to nearly $288 million and positioning the company to advance pivotal clinical trials and commercial preparations for its cancer-fighting radiopharmaceuticals.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.